Skip to main navigation Skip to search Skip to main content

Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART

Research output: Contribution to journalArticle

Abstract

A prospective study was designed to evaluate the prevalence and determinants of glucose metabolism abnormalities (GMAs) among HIV-1-infected pregnant women receiving highly active antiretroviral therapy (HAART).
Original languageEnglish
Pages (from-to)403-412
Number of pages10
JournalHIV Clinical Trials
Volume10
DOIs
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adolescent
  • Adult
  • Antiretroviral Therapy, Highly Active
  • Diabetes, Gestational
  • Female
  • Glucose Intolerance
  • Glucose Tolerance Test
  • HIV Infections
  • HIV Protease Inhibitors
  • HIV-1
  • Hepacivirus
  • Hepatitis C
  • Humans
  • Nevirapine
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Prevalence
  • Prospective Studies
  • Risk Factors

Fingerprint

Dive into the research topics of 'Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART'. Together they form a unique fingerprint.

Cite this